P A Fischer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralBasal Ganglia Diseases/chemically inducedCarboxy-Lyases/antagonists & inhibitorsDepression/etiologyDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/metabolismDihydroxyphenylalanine/therapeutic useDrug Therapy, CombinationGastrointestinal Diseases/chemically inducedGermany, WestHumansIntelligenceParkinson Disease, Secondary/complicationsParkinson Disease, Secondary/drug therapyParkinson Disease, Secondary/epidemiologyParkinson Disease, Secondary/pathologyPsychoses, Substance-Induced/etiologySerotonin/metabolismSleep Wake Disorders/drug therapySleep Wake Disorders/etiologyVanillic Acid/cerebrospinal fluid
Substances: See more » SerotoninDihydroxyphenylalanineCarboxy-LyasesVanillic Acid
Year: 1974 PMID: 4614096
Source DB: PubMed Journal: Nervenarzt ISSN: 0028-2804 Impact factor: 1.214